|
|
|
|
Direct Cost |
Indirect Cost |
|
| 1F31HL176188-01 |
The growth factor meteorin-like and its receptor KIT in heart failure |
HANNOVER MEDICAL SCHOOL |
NHLBI |
$29,270 |
|
$29,270 |
| 1F31HL176188-01X1 |
The growth factor meteorin-like and its receptor KIT in heart failure |
HANNOVER MEDICAL SCHOOL |
NHLBI |
$4,750 |
|
$4,750 |
| 1K43TW013136-01 |
Implementing screening and brief intervention for substance use in primary care in rural Georgia |
DAVID TVILDIANI MEDICAL UNIVERSITY LLC |
FIC |
$109,223 |
$8,482 |
$117,705 |
| 1R01AG085446-01A1 |
Systems Genetics Analysis of Resilience to Tauopathy in ADRD |
UNIVERSITY COLLEGE LONDON |
NIA |
$743,177 |
$56,523 |
$799,700 |
| 1R01AI185516-01A1 |
Dissecting the role of vaccine-promoted Th17 cells in protective immunity against tuberculosis |
STATENS SERUM INSTITUTE |
NIAID |
$645,732 |
$20,835 |
$666,567 |
| 1R01AI186964-01 |
The role of cell, antigen, and antibody, in controlling virus infection through Fc-dependent mechanisms |
CARDIFF UNIVERSITY |
NIAID |
$294,523 |
$23,562 |
$318,085 |
| 1U01NS142093-01 |
X-ray nanotomography for scalable connectomics |
FRANCIS CRICK INSTITUTE, LTD |
NINDS |
$963,401 |
$46,257 |
$1,009,658 |
| 2R01AG065596-03 |
Serum protein markers along the Alzheimer's disease trajectory in the population-based longitudinal AGES Reykjavik study and their offsprings |
ICELANDIC HEART ASSOCIATION |
NIA |
$433,722 |
$155,449 |
$589,171 |
| 2U24HG007234-13 |
GENCODE: comprehensive gene annotation for human and mouse |
EUROPEAN MOLECULAR BIOLOGY LABORATORY |
NHGRI |
$2,521,053 |
$139,972 |
$2,661,025 |
| 3OT2CA262137-01S4 |
Cancer Grand Challenges: Operations Management Application |
CANCER RESEARCH UNITED KINGDOM |
NCI |
$1,640,929 |
|
$1,640,929 |
| 3R01AG017644-26S1 |
English Longitudinal Study of Ageing - Renewal 2024 |
UNIVERSITY COLLEGE LONDON |
NIA |
$2,298,269 |
$183,862 |
$2,482,131 |
| 3R01AI177376-03S1 |
Broad spectrum protection and immune responses induced by an NP-based universal influenza vaccine in heterologous NHP challenge model |
OSIVAX SAS |
NIAID |
$342,733 |
$27,419 |
$370,152 |
| 3R01NS134015-03S1 |
Altered Microglia States and Microglia-Endothelial Cell Axis in Relation to White Matter Disease Progression in VCID |
UNIVERSITY OF EDINBURGH |
NINDS |
$86,485 |
$6,919 |
$93,404 |
| 3R37CA275824-03S1 |
A novel, one stop, affordable, point of care and artificial intelligence supported system of screening, triage and treatment selection for cervical cancer and precancer in the LMICs |
INTERNATIONAL AGENCY FOR RES ON CANCER |
NCI |
$84,457 |
$6,757 |
$91,214 |
| 3R37CA275824-03S2 |
A novel, one stop, affordable, point of care and artificial intelligence supported system of screening, triage and treatment selection for cervical cancer and precancer in the LMICs |
INTERNATIONAL AGENCY FOR RES ON CANCER |
NCI |
$278,877 |
$22,310 |
$301,187 |
| 3R37CA284134-03S1 |
Quantitative background parenchymal enhancement, measured on contrast-enhanced mammogram, as a novel marker of breast cancer risk |
NETHERLANDS CANCER INSTITUTE |
NCI |
$57,003 |
$4,560 |
$61,563 |
| 3U01AI069924-20S1 |
International epidemiology Databases to Evaluate AIDS (IeDEA) Southern Africa. |
UNIVERSITAT BERN |
NIAID |
$339,887 |
$27,191 |
$367,078 |
| 3U01AI069924-20S2 |
International epidemiology Databases to Evaluate AIDS (IeDEA) Southern Africa. |
UNIVERSITAT BERN |
NIAID |
$694,188 |
$55,535 |
$749,723 |
| 3U01AI069924-20S3 |
International epidemiology Databases to Evaluate AIDS (IeDEA) Southern Africa. |
UNIVERSITAT BERN |
NIAID |
$216,604 |
$5,248 |
$221,852 |
| 3U01AI069924-20S4 |
International epidemiology Databases to Evaluate AIDS (IeDEA) Southern Africa. |
UNIVERSITAT BERN |
NIAID |
$76,767 |
$3,741 |
$80,508 |